FDA Approves Stiolto® Respimat® sNDA to Add Data on COPD | BI US
FDA approves labeling for Stiolto® Respimat® (tiotropium bromide & olodaterol) with data showing reduction in COPD exacerbations. View ISI, PI & Med Guide.
Search
Full results from EMPERIAL exercise ability trials presented
Full results from EMPERIAL exercise ability trials presented
Facing Lung Cancer: Keith’s Story
Facing Lung Cancer: Keith’s Story
Welcome to Animal Health Partnering
Welcome to Animal Health Partnering
Beyond the Stigma: Living with Schizophrenia
Beyond the Stigma: Living with Schizophrenia
Clinical Pharmacology
Boehringer Ingelheim is proud to offer a new two-year fellowship within Clinical Pharmacology. Click here to find out more.
Submit Your Partnering Opportunity
Submit Your Partnering Opportunity
Taking KRAS Cancer On
Taking KRAS Cancer On
Our Partnering Approach
Our Partnering Approach
We’re All In
We’re All In
Ingelheim
The company headquarters of Boehringer Ingelheim are located in Ingelheim, Germany.
Our Businesses
Our Businesses
Vaccines
Vaccines
Empowering Patients
Empowering Patients
Partnering Culture
BI's long-term research and investment focus means we can work together to realize their ideas by fully committing to lasting relationships.
Get in touch
Get in touch
Summer Internship Program
CAREER AREAS
Argentina
Argentina
China
China
Singapore
Singapore
Spain
Spain
Internships and Co-Ops
Would you like the opportunity to experience what it is like to work at an innovative global pharmaceutical company? Click here to find out more.
Moving to Germany
We started in Germany, but we have offices all over the world.
Cooperative Learning Program
CAREER AREAS
Corporate Strategy & Consulting
Corporate Strategy & Consulting